Abstract YO7
Case summary
Introduction:
The orbit is an unusual site for metastatic cancer. Orbital metastasis is believed to occur in approximately 2% to 3% of patients with systemic cancer.
Case Presentation:
A 58-year-old male with history of three month history of on and off orbital swelling presented with right hip pain. He had a history of high-risk prostate cancer July 2019 status post radical prostatectomy, leuprolide and salvage radiotherapy. He was put on androgen deprivation therapy(ADT) break from December 2021 until repeat PSA in April 2022 was 107. A repeat CT-CAP and bone scan on 4/21/2022 which showed diffuse bony metastasis including R iliac wing and calvarium. Patient was started on degarelix and sent to a medical oncologist. He was started on leuprolide and enzalutamide and received palliative radiotherapy for right hip pain. During his radiotherapy patient developed worsening right hip pain for which he had to be admitted.On day 3 of admission patient developed significant chemosis, significant extraocular muscle restriction particularly in abduction. CT Scan of the maxillofacial region showed significant right periorbital swelling with potential post septal involvement noted on the right. Multiple calvarial lesions were also noted. Magnetic resonance imaging (MRI) head showed tumor infiltration of the skull base and frontal bones with intraorbital extraconal subperiosteal tumor and bifrontal epidural tumor extension. Steroids were started. Periorbital swelling resolved on day 6. Biopsy was deferred.
Discussion
The median age for orbital metastasis reported is at 70 years however our patient is younger. In general, patients present with ocular symptoms such as decreased vision, diplopia, proptosis and periorbital edema. Metastatic cancer most commonly develops in the uveal tract. Metastasis to the retina, optic disc, and vitreous are relatively uncommon. Metastasis to the bony orbit although rare, has been reported in the past. Extraconal space is the area outside musculofascial cone in the eye. Although both bony and soft tissue metastasis involving the uveal tract have been reported in the past, extraconal orbital soft tissue metastasis secondary to PC is only reported once and is extremely rare.Treatment options include ADT and cranial irradiation.
Clinical trial identification
Editorial acknowledgement
Resources from the same session
419P - Breast arterial calcifications on mammogram and its clinical implications
Presenter: Pradeep Kumar Kistampally
Session: Poster viewing 06
420P - Predictive factors of post-operative acute kidney injury after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis: A retrospective cohort study
Presenter: Chito Cabiling
Session: Poster viewing 06
421P - The association between early changes in neutrophil-lymphocyte ratio and survival in patients treated with immunotherapy
Presenter: Deniz Can Guven
Session: Poster viewing 06
422P - Molecular mechanism in prostate cancer with TP53 mutation
Presenter: Bin Hu
Session: Poster viewing 06
423P - Maintaining a national essential medicine list for cancer in Malaysia: Where do we stand?
Presenter: David Lee
Session: Poster viewing 06
424P - The Storm: Paraneoplastic leucomoid reaction - A bad prognostic factor
Presenter: Abdullah Al Mamun Khan
Session: Poster viewing 06
425P - Preliminary study: Assessment of public trust in traditional medicine and medical treatment in cancer patients in Indonesia - Study validity and reliability of the Universitas Sebelas Maret Trust and readiness assessment for cancer patients (UNS – TRAfCP35) questionnaire
Presenter: Widyanti Soewoto
Session: Poster viewing 06
426P - Safety of Sputnik V COVID-19 vaccine in cancer patients receiving chemotherapy: An observational study
Presenter: Alexey Rumyantsev
Session: Poster viewing 06
427P - Oncology combination therapies in Asia-Pacific markets: What are the current access challenges?
Presenter: Gayathri Kumar
Session: Poster viewing 06
428P - Clinical characteristics, laboratory parameters, and hospital outcomes of COVID-19 among patients with and without cancer: A retrospective cohort study
Presenter: PRASHANT SIROHIYA
Session: Poster viewing 06